Research suggests that Lactobacillus casei, as part of a multi-strain probiotic formulation, is generally safe and well-tolerated in healthy adults, with probiotic strains detectable in stool following supplementation. The available evidence, currently limited to a single randomized, double-blind, placebo-controlled trial, showed only modest shifts in gut microbial composition, which researchers attributed to the already-healthy baseline state of participants rather than a lack of effect from the supplement itself. Studies indicate that the digestive benefits of such formulations may be more pronounced in populations with existing gut dysbiosis, such as those with obesity or metabolic disorders, though this remains to be tested directly. Overall, the evidence base is quite limited, and broader conclusions about Lactobacillus casei for digestive health in diverse populations cannot yet be drawn from this single study alone.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement o... | RCT | 2021 | Mixed | 100 |